Iptacopan in Patients With ANCA Associated Vasculitis
Clinical trial NCT06388941 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06388941
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-05
- Primary completion
- 2026-12-30
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.